Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2020
A microdose clinical trial to evaluate [<sup>18</sup>F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
Inki Lee, Ilhan Lim, Byung Hyun Byun, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2014
The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy
Ilhan Lim, Woo Chul Noh, Jihyun Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Ilhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2021
A Comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF, and <sup>18</sup>F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
Synapse (New York, N.Y.)
|
February 28, 2018
Head-to-head comparison of <sup>18</sup> F-FP-CIT and <sup>123</sup> I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study
Inki Lee, Jin Su Kim, Joon Yeun Park, et al.
Radiology
|
July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI
Liza Lindenberg, Esther Mena, Baris Turkbey, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
January 17, 2020
Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial
Inki Lee, Hae Ri Na, Byung Hyun Byun, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 14, 2023
Radioimmunotherapy with <sup>131</sup> I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma
Yoon Jung Jang, Sang Moo Lim, Inki Lee, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2020
A microdose clinical trial to evaluate [<sup>18</sup>F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
Inki Lee, Ilhan Lim, Byung Hyun Byun, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2014
The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy
Ilhan Lim, Woo Chul Noh, Jihyun Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Ilhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2021
A Comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF, and <sup>18</sup>F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
Synapse (New York, N.Y.)
|
February 28, 2018
Head-to-head comparison of <sup>18</sup> F-FP-CIT and <sup>123</sup> I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study
Inki Lee, Jin Su Kim, Joon Yeun Park, et al.
Radiology
|
July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI
Liza Lindenberg, Esther Mena, Baris Turkbey, et al.
Journal of Clinical Neurology (Seoul, Korea)
|
January 17, 2020
Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial
Inki Lee, Hae Ri Na, Byung Hyun Byun, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 14, 2023
Radioimmunotherapy with <sup>131</sup> I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma
Yoon Jung Jang, Sang Moo Lim, Inki Lee, et al.
Page
of 7